JMP Securities analyst Jason N. Butler reiterated a Market Outperform rating and $10.00 price target on Marinus Pharmaceuticals (NASDAQ: MRNS).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Truist Securities Reiterates Buy Rating on Marinus Pharmaceuticals (MRNS)August 13, 2024 4:04 PM Form 10-Q MARINUS PHARMACEUTICALS, For: Jun 30August 13, 2024 8:01 AM Form 8-K MARINUS PHARMACEUTICALS, For: Aug 13August 13, 2024 7:10 AM Marinus Pharma (MRNS) Misses Q2 EPS by 4c ; Offers GuidanceAugust 13, 2024 7:05 AM Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 7:00 AM